Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01664533
Brief Title: An Observational Study of Erlotinib (Tarceva) as Second-line Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Pemetrexed in First-line Therapy (TIME)

First Submitted : August 10, 2012
First Submitted that Met QC Criteria : August 10, 2012
First Posted : August 14, 2012 (Estimate)

Results First Submitted : October 9, 2015
Results First Submitted that Met QC Criteria : November 23, 2015
Results First Posted : December 28, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : November 23, 2015
Last Update Posted : December 28, 2015 (Estimate)